気管支炎治療の世界市場

◆英語タイトル:Bronchitis Treatment - Global Market Outlook (2015-2022)
◆商品コード:SMRC65042
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:121
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、気管支炎治療の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・気管支炎治療の世界市場:薬品種類別分析/市場規模
・気管支炎治療の世界市場:治療別分析/市場規模
・気管支炎治療の世界市場:需要先別分析/市場規模
・気管支炎治療の世界市場:地域別分析/市場規模
・気管支炎治療のアメリカ市場規模予測
・気管支炎治療のヨーロッパ市場規模予測
・気管支炎治療のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Bronchitis Treatment Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Sedentary lifestyle, chemical pollutants, strict regulations to pollutant emission control, habit to cigarette smoke and adherence to a variety of international protocol are the major factors driving the market growth. Chemicals, smoke, air pollution and irritants are the risk factors for bronchitis. The most important indication of bronchitis is headache, continuous cough, nasal congestion, sore throat and fatigue.
Some of the key players in the market include GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Osiris Therapeutics, Inc., Pfizer Inc., Reddy’s Laboratories Ltd, Sanofi Aventis, Hyundai Pharmaceutical Co., Ltd., Mucosis B.V. , Myelo Therapeutics GmbH, DBV Technologies S.A., Recipharm and Dr. Reddy’s Laboratories Ltd.

Class of Drugs Covered:
• Bronchodilators
• Mucolytics
• Antibiotics
• Anti-inflammatory Drugs

Treatments Covered:
• Oxygen therapy
• Drugs

End Users Covered:
• Drug stores
• Hospitals
• Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bronchitis Treatment Market, By Class of Drugs
5.1 Introduction
5.2 Bronchodilators
5.3 Mucolytics
5.4 Antibiotics
5.5 Anti-inflammatory Drugs

6 Global Bronchitis Treatment Market, By Treatment
6.1 Introduction
6.2 Oxygen therapy
6.3 Drugs

7 Global Bronchitis Treatment Market, By End User
7.1 Introduction
7.2 Drug stores
7.3 Hospitals
7.4 Clinics

8 Global Bronchitis Treatment Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 GlaxoSmithKline Pharmaceuticals Limited
10.2 Boehringer Ingelheim
10.3 Osiris Therapeutics, Inc.
10.4 Pfizer Inc.
10.5 Reddy’s Laboratories Ltd
10.6 Sanofi Aventis
10.7 Hyundai Pharmaceutical Co., Ltd.
10.8 Mucosis B.V.
10.9 Myelo Therapeutics GmbH
10.10 DBV Technologies S.A.
10.11 Recipharm
10.12 Dr. Reddy’s Laboratories Ltd

List of Tables
Table 1 Global Bronchitis Treatment Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 3 Global Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 4 Global Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 5 Global Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 6 Global Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 7 Global Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 8 Global Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 9 Global Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 10 Global Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 11 Global Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 12 Global Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 13 Global Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 14 North America Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 15 North America Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 16 North America Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 17 North America Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 18 North America Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 19 North America Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 20 North America Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 21 North America Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 22 North America Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 23 North America Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 24 North America Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 25 North America Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 26 Europe Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 27 Europe Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 28 Europe Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 29 Europe Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 30 Europe Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 31 Europe Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 32 Europe Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 33 Europe Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 34 Europe Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 35 Europe Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 36 Europe Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 37 Europe Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 38 Asia Pacific Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 39 Asia Pacific Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 40 Asia Pacific Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 41 Asia Pacific Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 42 Asia Pacific Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 43 Asia Pacific Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 44 Asia Pacific Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 45 Asia Pacific Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 46 Asia Pacific Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 47 Asia Pacific Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 48 Asia Pacific Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 49 Asia Pacific Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)
Table 50 Rest of the World Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
Table 51 Rest of the World Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
Table 52 Rest of the World Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
Table 53 Rest of the World Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
Table 54 Rest of the World Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
Table 55 Rest of the World Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
Table 56 Rest of the World Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
Table 57 Rest of the World Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
Table 58 Rest of the World Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 59 Rest of the World Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
Table 60 Rest of the World Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 61 Rest of the World Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)



【レポートのキーワード】

気管支炎、気管支炎治療、気管支炎薬、酸素治療、気管支拡張薬、粘液溶解薬

★調査レポート[気管支炎治療の世界市場]販売に関する免責事項
★調査レポート[気管支炎治療の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆